Cost-Effectiveness of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
JAMA Cardiol 2023 Mar 04;[EPub Ahead of Print], LP Cohen, N Isaza, I Hernandez, GD Lewis, JE Ho, GC Fonarow, DS Kazi, BK BellowsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.